Largest pharmaceutical companies in the United Kingdom by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

AstraZeneca leads the 4 pharmaceutical companies in the United Kingdom ranked by net assets, at SAR 182.5B, ahead of GSK (SAR 81.5B) and Roivant Sciences (SAR 17B). Figures as of 20 Nov 2026, 04:02 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
4
First
AstraZenecaSAR 182.5B
Median
SAR 49.3B
Combined market value
SAR 1.51T
Countries
1

Market values as of .

United Kingdom
All sectors
Pharmaceuticals
SAR
Clear filters
Largest pharmaceutical companies in the United Kingdom by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AstraZenecaAZN · Health CareSAR 182.5BSAR 1.02TSAR 657.96 1.87% down 1% up United Kingdom
2GSKGSK · Health CareSAR 81.5BSAR 359.5BSAR 179.37 1.56% down 5% up United Kingdom
3Roivant SciencesROIV · Health CareSAR 17BSAR 105.9BSAR 146.14 0.59% up 91% up United Kingdom
4Kiniksa Pharmaceuticals InternationalKNSA · Health CareSAR 2.1BSAR 27.6BSAR 350.85 1.59% down 129% up United Kingdom

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).

Questions and answers

Which pharmaceutical companies in the United Kingdom rank first by net assets?

AstraZeneca (SAR 182.5B), GSK (SAR 81.5B) and Roivant Sciences (SAR 17B) are the top three of the 4 pharmaceutical companies in the United Kingdom ranked by net assets as of 20 Nov 2026, 04:02 UTC.

How many pharmaceutical companies in the United Kingdom are in this ranking?

4 are ranked by net assets.

What are these pharmaceutical companies in the United Kingdom worth together?

The 4 pharmaceutical companies in the United Kingdom ranked by net assets have a combined market value of SAR 1.51T as of 20 Nov 2026, 04:02 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest pharmaceutical companies in the United Kingdom by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-kingdom&by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.